CompletedPHASE1, PHASE2NCT05065905

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
SPP Pharmaclon Ltd.
Principal Investigator
Vladimir Shmelev, Doctor
SPP Pharmaclon Ltd.
Intervention
Interferon-Gamma(drug)
Enrollment
78 enrolled
Eligibility
18-50 years · All sexes
Timeline
20062006

Study locations (2)

Collaborators

North-Western State Medical University named after I.I.Mechnikov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05065905 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials